Has Richard Galloway, MD received payments from drug or device companies?

Yes. Drug and device makers reported $108,654 in general payments to Richard Galloway, MD across 282 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Galloway, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Galloway, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Galloway, MD

Endocrinology, Diabetes & Metabolism · Hattiesburg, MSNPI 1376553222

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $95,331 of the $108,654 with a category attached, or 87.7%. Novo Nordisk accounts for 62.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $70,339 and has fallen 84.9% since, to $10,593 in 2022.

$108,654in general payments, 2019–2025

Across 282 payments — averaging $385.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$68K
Amgen$23K
Boehringer Ingelheim$10K
Lilly USA, LLC$6K
Sanofi-aventis U.S. LLC$230
AstraZeneca$185
plus $960 from 15 others

What the payments were for

Consulting fees$3,5753%
Speaking & faculty fees$95,33188%
Travel & lodging$6,0286%
Food & beverage$3,7053%
Education$150%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	94	$67,535
Amgen	56	$23,399
Boehringer Ingelheim	25	$10,236
Lilly USA, LLC	20	$6,109
Sanofi-aventis U.S. LLC	15	$230
AstraZeneca	13	$185
AbbVie	11	$184
Abbott	7	$138
Radius Health, Inc.	4	$104
Medtronic	8	$98
Merck	5	$65
BD	4	$59
Regeneron Healthcare Solutions, Inc.	4	$58
Insulet Corporation	2	$45
Amarin Pharma, Inc.	3	$42
Integra Lifesciences Corporation	2	$32
Shire North American Group Inc	2	$32
Johnson & Johnson	2	$29
Corcept Therapeutics	2	$29
Medline Industries LP	2	$27
Smith+Nephew	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Ozempic$33,465
Repatha$22,559
RYBELSUS$16,070
JARDIANCE$15,719
Tresiba$14,146

How this compares

$108,654 in reported general payments places this provider in the 85th percentile of 48 endocrinology, diabetes & metabolism providers in Mississippi.

See all endocrinology, diabetes & metabolism providers in Mississippi →

Medicare billing

Part B allowed, 2024

$2,814

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Hattiesburg

James PowellHattiesburg$88K
Jaya NaranHattiesburg$3K
Aboorva Kambiliampatti SudhakarHattiesburg$1K
Daniel McCallHattiesburg$1K
Dana DaleHattiesburg$300
Eric DyessJackson$885K
Mark BorcheltGulfport$722K
Honey EastJackson$721K
Ben SealeJackson$623K
Jeremy TaylorMadison$271K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →